The Russian Fishery Company purchased medicines for the new coronavirus infection treatment for the Regional Clinical Dermatovenerologic Dispensary in Vladivostok.
The hospital received the drug "Favipiravir". Favipiravir is approved for treatment of patients with a new coronavirus infection (COVID-19) in a hospital setting.
“This drug is one of the key antiviral drugs. We are very grateful to the Russian Fishery Company for the opportunity to receive the most important medicine for our patients. For our hospital, this is timely and very valuable help, - said Anatoly Gerets, chief physician of the Regional Clinical Dermatovenerologic Dispensary.
The Russian Fishery Company provides systematic charitable support to medical institutions in Primorye in the fight against coronavirus. Previously, the company financed the purchase of medicines for the treatment of severe acute pneumonia for the Regional Children's Clinical Hospital No. 2 in Vladivostok. In addition to medicines, the RFC transferred 15 tons of Pollock to the medical institutions of the Primorsky Territory for organizing meals for staff and patients. 18 hospitals in Vladivostok, Artem and Ussuriysk received fish products from the RFC.
“The safety and health of the Primorye residents have become a priority not only for the authorities and doctors, but also for business. We hope that by joint efforts we will be able to cope with the virus and stabilize the epidemiological situation in the region,” said Viktor Litvinenko, General Director of the Russian Fishery Company.
